Stuttgart - Delayed Quote EUR

Ligand Pharmaceuticals Inc (LGDN.SG)

95.50
+2.50
+(2.69%)
At close: 9:48:09 PM GMT+2
Loading Chart for LGDN.SG
  • Previous Close 93.00
  • Open 94.50
  • Bid 95.50 x 150000
  • Ask 97.00 x 150000
  • Day's Range 94.50 - 95.50
  • 52 Week Range 72.00 - 119.00
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: LGDN.SG

View More

Performance Overview: LGDN.SG

Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LGDN.SG
8.17%
S&P 500 (^GSPC)
0.64%

1-Year Return

LGDN.SG
20.13%
S&P 500 (^GSPC)
11.90%

3-Year Return

LGDN.SG
106.58%
S&P 500 (^GSPC)
48.70%

5-Year Return

LGDN.SG
55.83%
S&P 500 (^GSPC)
103.62%

Compare To: LGDN.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LGDN.SG

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    1.80B

  • Enterprise Value

    1.61B

  • Trailing P/E

    --

  • Forward P/E

    17.12

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.73

  • Price/Book (mrq)

    2.53

  • Enterprise Value/Revenue

    9.97

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: LGDN.SG

View More

Company Insights: LGDN.SG

Research Reports: LGDN.SG

View More